Deepak Vangala

2.3k total citations
22 papers, 212 citations indexed

About

Deepak Vangala is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Deepak Vangala has authored 22 papers receiving a total of 212 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Pathology and Forensic Medicine and 6 papers in Molecular Biology. Recurrent topics in Deepak Vangala's work include Cancer Genomics and Diagnostics (6 papers), Genetic factors in colorectal cancer (5 papers) and Acute Myeloid Leukemia Research (4 papers). Deepak Vangala is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Genetic factors in colorectal cancer (5 papers) and Acute Myeloid Leukemia Research (4 papers). Deepak Vangala collaborates with scholars based in Germany, Belgium and Spain. Deepak Vangala's co-authors include Roland Schroers, Wanda M. Gerding, Huu Phuc Nguyen, Thomas Mika, Wolff Schmiegel, Estelle Cauchin, Ulrich Güller, Judith Balmañà, Fátima Carneiro and Tamara Matysiak‐Budnik and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Deepak Vangala

21 papers receiving 211 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deepak Vangala Germany 8 90 66 62 55 41 22 212
Juliana Craig United States 8 63 0.7× 40 0.6× 126 2.0× 49 0.9× 50 1.2× 16 211
Dominique Penther France 7 73 0.8× 74 1.1× 67 1.1× 36 0.7× 52 1.3× 13 219
Kaiyang Ding China 9 36 0.4× 107 1.6× 113 1.8× 28 0.5× 100 2.4× 51 241
Herlander Marques Portugal 9 44 0.5× 19 0.3× 59 1.0× 81 1.5× 112 2.7× 25 247
Federica Lovisa Italy 11 92 1.0× 63 1.0× 60 1.0× 86 1.6× 115 2.8× 23 271
Corina Schneidawind Germany 12 36 0.4× 118 1.8× 84 1.4× 18 0.3× 138 3.4× 25 302
Yeo‐Kyeoung Kim South Korea 7 54 0.6× 119 1.8× 67 1.1× 12 0.2× 93 2.3× 9 236
Gaixiang Xu China 7 55 0.6× 46 0.7× 42 0.7× 14 0.3× 59 1.4× 26 193
Ryan J. Stubbins Canada 9 37 0.4× 102 1.5× 80 1.3× 21 0.4× 94 2.3× 26 286
Elizabeth Budde United States 9 63 0.7× 88 1.3× 161 2.6× 15 0.3× 105 2.6× 26 275

Countries citing papers authored by Deepak Vangala

Since Specialization
Citations

This map shows the geographic impact of Deepak Vangala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepak Vangala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepak Vangala more than expected).

Fields of papers citing papers by Deepak Vangala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deepak Vangala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepak Vangala. The network helps show where Deepak Vangala may publish in the future.

Co-authorship network of co-authors of Deepak Vangala

This figure shows the co-authorship network connecting the top 25 collaborators of Deepak Vangala. A scholar is included among the top collaborators of Deepak Vangala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deepak Vangala. Deepak Vangala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vangala, Deepak, Thomas Seufferlein, & Robert Hüneburg. (2025). Lynch Syndrome in Context of the Updated German S3 Guideline Colorectal Cancer: Implementation of Universal MMR/MSI Testing. Oncology Research and Treatment. 49(3). 165–173. 1 indexed citations
2.
Vangala, Deepak, Thomas Mika, Alexander Kreuter, et al.. (2024). High-dose chemotherapy and autologous hematopoietic stem cell transplantation for progressive systemic sclerosis: a retrospective study of outcome and prognostic factors. Journal of Cancer Research and Clinical Oncology. 150(6). 301–301. 3 indexed citations
3.
Gerding, Wanda M., et al.. (2023). Optical Genome Mapping for Cytogenetic Diagnostics in AML. Cancers. 15(6). 1684–1684. 24 indexed citations
4.
Schroers, Roland, et al.. (2023). Optical Genome Mapping Reveals and Characterizes Recurrent Aberrations and New Fusion Genes in Adult ALL. Genes. 14(3). 686–686. 16 indexed citations
5.
Gerding, Wanda M., Stefan Wieczorek, Thomas Mika, et al.. (2023). Novel NUP98::ASH1L Gene Fusion in Acute Myeloid Leukemia Detected by Optical Genome Mapping. Cancers. 15(11). 2942–2942. 10 indexed citations
6.
Seifert, Nicole, Deepak Vangala, Sabine Seidel, et al.. (2023). Treatment Strategies and Prognostic Factors in Secondary Central Nervous System Lymphoma: A Multicenter Study of 124 Patients. HemaSphere. 7(8). e926–e926. 2 indexed citations
7.
Maghnouj, Abdelouahid, Ting Li, Berlinda Verdoodt, et al.. (2023). Lasting response by vertical inhibition with cetuximab and trametinib inKRAS‐mutated colorectal cancer patient‐derived xenografts. Molecular Oncology. 17(11). 2396–2414. 4 indexed citations
8.
Vangala, Deepak, et al.. (2023). Neue medikamentöse Konzepte bei Patienten mit kolorektalen Karzinomen und Mikrosatelliteninstabilität. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 148(6). 475–482.
9.
Klein‐Scory, Susanne, et al.. (2023). Repeated Infusions of Brexucabtagene-autoleucel in Relapsed/Refractory Mantle Cell Lymphoma. HemaSphere. 7(9). e949–e949. 2 indexed citations
10.
Gerding, Wanda M., Thomas Mika, Matthias Eckhardt, et al.. (2022). Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients. International Journal of Cancer. 150(12). 1998–2011. 42 indexed citations
11.
Vangala, Deepak, et al.. (2022). Treatment of leptomeningeal disease in blastic plasmacytoid dendritic cell neoplasm following tagraxofusp-erzs induction. Haematologica. 107(8). 2004–2007. 2 indexed citations
12.
Gerding, Wanda M., Joanna M. Lubieniecka, Thomas Liehr, et al.. (2022). Broad genomic workup including optical genome mapping uncovers a DDX3X: MLLT10 gene fusion in acute myeloid leukemia. Frontiers in Oncology. 12. 959243–959243. 3 indexed citations
13.
Mika, Thomas, Deepak Vangala, Matthias Eckhardt, et al.. (2021). Case Report: Hemophagocytic Lymphohistiocytosis and Non-Tuberculous Mycobacteriosis Caused by a Novel GATA2 Variant. Frontiers in Immunology. 12. 682934–682934. 6 indexed citations
14.
15.
Mika, Thomas, Deepak Vangala, Alexander Baraniskin, et al.. (2021). Quantification of cell-free DNA for the analysis of CD19-CAR-T cells during lymphoma treatment. Molecular Therapy — Methods & Clinical Development. 23. 539–550. 8 indexed citations
16.
Mika, Thomas, Alexander Baraniskin, Deepak Vangala, et al.. (2019). Allogeneic hematopoietic stem cell transplantation for primary central nervous system lymphoma. Haematologica. 105(4). e160–e163. 6 indexed citations
17.
Vangala, Deepak, Christian Pox, Christoph Engel, et al.. (2018). Clinical characteristics and EGD surveillance in Lynch-syndrome patients with small bowel/duodenal carcinomas.. Journal of Clinical Oncology. 36(15_suppl). 1555–1555. 2 indexed citations
18.
Vangala, Deepak, Christian Pox, Christoph Engel, et al.. (2018). Value of EGD for gastric cancer surveillance in patients with hereditary non-polyposis colorectal cancer (HNPCC) or Lynch syndrome (LS).. Journal of Clinical Oncology. 36(15_suppl). 1522–1522. 3 indexed citations
19.
20.
Buchholz, Malte, Stephan A. Hahn, Deepak Vangala, et al.. (2017). Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivo. BMC Cancer. 17(1). 216–216. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juliana Craig Breakdown of academic impact, for papers by Dominique Penther Breakdown of academic impact, for papers by Kaiyang Ding Breakdown of academic impact, for papers by Herlander Marques Breakdown of academic impact, for papers by Federica Lovisa Breakdown of academic impact, for papers by Corina Schneidawind Breakdown of academic impact, for papers by Yeo‐Kyeoung Kim Breakdown of academic impact, for papers by Gaixiang Xu Breakdown of academic impact, for papers by Ryan J. Stubbins Breakdown of academic impact, for papers by Elizabeth Budde
Rankless by CCL
2026